Macédoine du Nord - Fournitures d'angiographie - Achat de matériel médical consommable pour la cardiologie interventionnelle - stents coronaires
Acheteur: Public Health Institution Specialized Hospital for prevention, treatment and rehabilitation of cardiovascular diseases - Ohrid
Pays: Macédoine du Nord
Date limite: 30 sept. 2026, 12:00 (UTC+2)
Valeur estimée: 479 674 €
Procédure: Procédure ouverte
Secteur (CPV): Équipements médicaux & produits pharmaceutiques (33111710)
Aperlena: https://aperlena.com/fr/t/north-macedonia-angiography-supplies-procurement-of-medical-dispensable-material-for-interventional-cardiology-cor-02190c1788
Avis officiel: https://ted.europa.eu/en/notice/-/detail/605445-2026
Les offres sont closes. Une attribution ou un rectificatif sur cet avis : un e-mail quand le registre le voit.
Se connecter
01
Résumé
Résumé généré automatiquement
L'acheteur était l'établissement public de santé, hôpital spécialisé pour la prévention, le traitement et la rééducation des maladies cardiovasculaires à Ohrid, en Macédoine du Nord. Il a acheté du matériel médical consommable pour la cardiologie interventionnelle, à savoir des stents coronaires. L'objet du marché comportait 11 parties distinctes, couvrant des stents en alliages de chrome, de cobalt ou de platine, avec polymères permanents, bioabsorbables ou biodégradables, revêtus d'un immunosuppresseur inhibant le m-TOR, avec des diamètres tels que 2,0-4,5mm et des longueurs telles que 9-50mm. La valeur estimée était de EUR 479 674. La procédure est Close pour les offres ; la date limite de remise des offres était le 2026-09-30.
02
Description
The subject of the agreement consists of 11 separate parts, including:
A coronary stent made of a chromium alloy (cobalt or platinum) with a continuous sinusoidal configuration and a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR; A coronary stent made of a chromium alloy (cobalt or platinum) with a bioabsorbable polymer and hybrid coating with an active component of an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR and a passive component that lowers the thrombogenicity; A coronary stent made of a chromium and cobalt alloy with an abluminal biodegradable polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR. Diameter 2.0-4.5mm, length 9-50mm.; A coronary stent made of a chromium and cobalt alloy with a hybrid cell design and a low stent crossing profile ≤ 0.041” (it refers to a stent with a diameter of up to 3mm), with a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR; A coronary stent made of multiple cobalt alloys (chromium or nickel) designed for large post-dilatation expansions ≥ 5.5mm in large blood vessels, with a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR; A coronary stent made of a chromium and platinum alloy with a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR; A coronary stent made of a chromium and platinum alloy with an abluminal biodegradable polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR, with a diameter from 2.25 to 5mm, length from 8 to 48mm, compatible with 5F guiding catheter for all dimensions; A coronary stent made of a chromium and cobalt alloy, with a polymer and carrier free technology, coated with an immunosuppressant on the abluminal surface that stops the cell cycle progression by inhibiting the m-TOR. - time of delivery of the medicine shall be 30 days or less, - effective length of the shaft 142cm+/3cm, - shaft diameter: proximal 2.1F or less, distal 2.6F or less - struts thickness: 85 micrometers or less, for a stent with a diameter of up to 3.0mm, - stent length: 9-36mm or longer, - stent diameter: 2.25-4.0mm or more, - maximum expansion of the stent diameter 5.95mm for stents with a diameter of 3.5mm and 4mm.; A coronary stent made of a chromium and cobalt alloy, with a biodegradable polymer (PLA) technology, coated with an immunosuppressant on the abluminal surface that stops the cell cycle progression by inhibiting the m-TOR. - time of delivery of the medicine and polymer absorption shall be synchronized, for 9 months or less, -Lesion entry profile: 0.017“ or less, - effective length of the shaft 142cm+/-3cm, - shaft diameter: proximal 2.0F or less, distal 2.6F or less - struts thickness: 85 micrometers or less, for a stent with a diameter of up to 3.0mm, - stent length: 9-36mm or longer, - stent diameter: 2.25-4.0mm or more, -maximum expansion of the stent diameter 5.95mm for stents with a diameter of 3.5mm and 4mm.; A coronary stent made of cobalt-chromium alloy, multi-link, featuring a Peak-to-Valley stent design for treatment of tapered (conically narrowed) coronary lesions with small and large diameters, coated with a permanent polymer and the cytostatic everolimus (DES). Strut thickness: 81 micrometers. Diameter range: 2 to 5 mm, length from 8 to 48 mm, and expandable up to 5.75 mm for diameters of 3.5 to 5.0 mm, and up to 3.75 mm for diameters of 2.0 to 3.25 mm, without shortening; A coronary cobalt-chromium stent with a permanent polymer, elastomer, featuring 4 markers, two positioned proximally and two distally, with a WZ stent design and a vessel wall imprint of 40 μm for the Z strut and 72 μm for the W strut with an exceptional radiopacity, with a metal spring tip at the catheter, enabling easier navigation through the blood vessels and improved visibility, coated with a drug from the LIMUS family, with diameters ranging from 2.25 to 4.00 mm and length from 8 to 44 mm, or equivalent
Source officielle
Source : TED - Tenders Electronic Daily (Publications Office of the EU)
Vérifiez toujours les détails dans l'avis officiel.
attribué à Production, trade and services company BI-MEK DOO Skopjejuil. 2026
Ne manquez plus aucun marché comme celui-ci
35 nouveaux avis pour Équipements médicaux & produits pharmaceutiques en Macédoine du Nord au cours des 7 derniers jours.
Recevez un e-mail quand de nouveaux avis paraissent. Gratuit.